Endotoxin contamination of apolipoprotein A-I: effect on macrophage proliferation--a cautionary tale

Xueting Jin1, Qing Xu1, Keith Champion2

  • 1Section of Experimental Atherosclerosis, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Atherosclerosis
|March 18, 2015
PubMed

Insights

Endotoxin contamination in apolipoprotein reagents significantly inhibits macrophage proliferation. This contamination, particularly free endotoxin, impacts cell assay results, even with removal procedures.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Immunology

Background:

  • Apolipoprotein reagents are crucial in biological research.
  • Observed variable effects of apolipoproteins on macrophage proliferation.
  • Potential for contaminants to influence experimental outcomes.

Purpose of the Study:

  • Investigate endotoxin contamination in apolipoprotein reagents.
  • Determine the impact of endotoxin on macrophage proliferation.
  • Assess the effectiveness of endotoxin removal methods.

Main Methods:

  • Bromodeoxyuridine incorporation cell proliferation assay.
  • Quantification of free and total endotoxin levels in apolipoprotein samples.
  • Testing apolipoprotein samples from various sources.

Main Results:

  • Human plasma ApoA-I (apolipoprotein A-I) inhibited macrophage proliferation by over 90% at 1 microg/ml.
  • Endotoxin alone potently inhibited macrophage proliferation (0.1 ng/ml caused >90% inhibition).
  • Free endotoxin, not protein-bound, was identified as the primary inhibitor.

Conclusions:

  • Endotoxin contamination is a significant confounding factor in apolipoprotein studies.
  • Macrophage proliferation assays are highly sensitive to endotoxin.
  • Standard endotoxin removal techniques may be insufficient due to endotoxin potency.